Inici › Mieloma múltiple › Minnesota › Minneapolis
Assaigs clínics de Mieloma múltiple a Minneapolis, MN
11 estudis de Mieloma múltiple busquen participants en centres de Minneapolis i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
ReclutantFase 3
- University Of Minnesota Medical Center, Minneapolis
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
ReclutantFase 2/3
- Minnesota Oncology - Minneapolis Clinic /ID# 278720, Minneapolis
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
ReclutantFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · a 5 mi
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
ReclutantFase 1/2
- Research Site, Minneapolis
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
ReclutantFase 2
- Masonic Cancer Center at University of Minnesota, Minneapolis
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
ReclutantFase 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- i 1 més
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Reclutant
- University of Minnesota - Masonic Cancer Center, Minneapolis
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
ReclutantFase 2
- Minnesota Oncology Hematology, Minneapolis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Allina Health Cancer Institute, Minneapolis
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
ReclutantFase 1/2
- University of Minnesota, Minneapolis
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
ReclutantEstudi observacional
- Center for International Blood and Marrow Transplant Research, Minneapolis
Assaigs de Mieloma múltiple en altres ciutats
- New York City, NY60 estudis
- Boston, MA42 estudis
- Atlanta, GA41 estudis
- Houston, TX38 estudis
- Durham, NC37 estudis
- Nashville, TN32 estudis
- Denver, CO27 estudis
- Rochester, MN24 estudis
- St. Louis, MO24 estudis
- Columbus, OH24 estudis
- Baldwin Park, CA23 estudis
- Chicago, IL22 estudis
Altres estudis a Minneapolis
- Càncer de mama27 estudis
- Càncer de pulmó de cèl·lules no petites26 estudis
- Càncer d'ovari24 estudis
- Càncer de pròstata23 estudis
- Càncer (tots els tipus)22 estudis
- Insuficiència cardíaca21 estudis
- Càncer de pulmó20 estudis
- Leucèmia mieloide aguda20 estudis
- Càncer colorrectal19 estudis
- Càncer d'endometri18 estudis
- Malaltia de Parkinson17 estudis
- Malaltia cardiovascular15 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.